Skip to main content
. 2021 Feb 26;13:2047–2055. doi: 10.2147/CMAR.S295952

Table 3.

Univariable and Multivariable Analysis

Univariable Analysis Multivariable Analysis
P value HR 95% CI P value HR 95% CI
LL UL LL UL
ALI 0.031 0.309 0.107 0.896 0.009 0.035 0.003 0.425
Gender 0.070 53.193 0.722 3918.139 0.952 260,285.584 0
Age 0.505 1.454 0.484 4.370
Smoking 0.005 6.280 1.750 22.534 0.538 0.492 0.051 4.704
PS 0.019 0.276 0.094 0.809
CCI=0 0.011 0.137
CCI=1-2 0.936 0.943 0.225 3.949 0.310 3.644 0.301 44.150
CCI≥3 0.006 7.011 1.739 28.267 0.046 9.355 1.037 84.381
ALB 0.675 1.236 0.458 3.336
WBC 0.669 0.806 0.299 2.170
RBC 0.093 43.222 0.534 3495.431 0.955 292,578.176 0
PLT 0.487 1.421 0.528 3.826
MONO 0.001 6.590 2.067 21.015 0.073 0.225 0.044 1.151
EO 0.023 3.562 1.194 10.632 0.094 5.371 0.750 38.493
BASO 0.012 3.711 1.335 10.314 0.475 0.567 0.120 2.685
NLR 0.069 0.384 0.137 1.079 0.323 2.090 0.484 9.022
LMR 0.567 0.045 0 1813.598
PLR 0.393 0.650 0.242 1.747
CEA 0.745 1.184 0.427 3.289
LDH 0.046 2.867 1.017 8.079 0.826 0.783 0.089 6.881
SCC 0.556 1.533 0.370 6.359
CYFRA21-1 0.127 2.284 0.790 6.599
NSE 0.152 2.074 0.765 5.624 0.329 0.319 0.032 3.156
BMI<18.5 0.243
BMI[18.5,25) 0.797 0.745 0.079 7.037
BMI≥25 0.114 2.383 0.812 6.991
CRP 0.926 1.053 0.357 3.103
Pro-GRP 0.960 0.946 0.110 8.136
Postoperative chemotherapy 0.644 0.775 0.263 2.283

Abbreviations: ALI, advanced lung cancer inflammation index; PS, performance status; CCI, Charlson comorbidity index; ALB, albumin; WBC, white blood cell; RBC, red blood cell; PLT, platelet; MONO, monocyte; EO, eosinophil; BASO, basophil; NLR, neutrophil to lymphocyte ratio; LMR, lymphocyte to monocyte ratio; PLR, platelet to lymphocyte ratio; CEA, carcinoembryonic antigen; LDH, lactate dehydrogenase; SCC, squamous cell carcinoma antigen; CYFRA 21–1, cytokeratin-19 fragment; NSE, neuron-specific enolase; BMI, body mass index; CRP, C-reactive protein; Pro-GRP, pro-gastrin releasing peptide.